NCT02577835

Brief Summary

This Registry is an investigator-initiated, international, multicenter, observational, prospective study aiming at: i) evaluating non-invasive 24-h ambulatory blood pressure and arterial stiffness estimates (through 24-h pulse wave analysis) in hypertensive subjects; ii) assessing the changes in estimates following treatment; iii) weighing the impact of 24-h pulse wave analysis on target organ damage and cardiovascular prognosis; iv) assessing the relationship between arterial stiffness, blood pressure absolute level and variability, and prognosis. Approximately 2000 subjects, referred to 20 hypertension clinics for routine diagnostic evaluation and follow-up of hypertension, will be recruited. Data collection will include ambulatory blood pressure monitoring, performed with a device allowing simultaneous non-invasive assessment of blood pressure and arterial stiffness, and clinical data (including cardiovascular outcomes). A web-based telemedicine platform will be used for data collection. Subjects will visit the centers at 6-12 month intervals. First follow-up results are expected to be available in the next 2-years. The results of the Registry will help defining the normalcy thresholds for current and future indices derived from 24-h pulse wave velocity, according to outcome data. They will also provide supporting evidence for the inclusion of such evaluation in recommendations on hypertension management.

Trial Health

93
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2015

Longer than P75 for all trials

Geographic Reach
9 countries

23 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 13, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 16, 2015

Completed
16 days until next milestone

Study Start

First participant enrolled

November 1, 2015

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
3.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2022

Completed
1.9 years until next milestone

Results Posted

Study results publicly available

March 1, 2024

Completed
Last Updated

December 16, 2024

Status Verified

October 1, 2024

Enrollment Period

3.1 years

First QC Date

October 13, 2015

Results QC Date

October 21, 2021

Last Update Submit

October 30, 2024

Conditions

Keywords

HypertensionArterial StiffnessAmbulatory blood pressure

Outcome Measures

Primary Outcomes (3)

  • 24-hour Pulse Wave Velocity (PWV)

    24-hour average value for arterial stiffness was assessed through estimation of the time traveled by the pulse wave from the central arterial tree (aorta) to the peripheral arteries (brachial artery) and measured in meters per sec. The faster the wave travels through the arterial tree, the stiffer the artery is.

    2 years

  • 24-hour Augmentation Index (AI)

    24-hour average value for waves reflection expressed as a percentage. The augmentation index is a measure of wave reflection and arterial stiffness and is commonly measured as the ratio of the central pulse pressure and the reflected pulse pressure which augments the central blood pressure. When arteries are stiff, a reflected wave is formed where arteries split. This reflected wave moves back at the heart and increases the pressure at which the heart has to pump. The higher the index the stiffer the artery is.

    2 years

  • 24-hour Central Blood Pressure

    24-hour average central aortic pressure expressed in mmHg, as the estimated blood pressure at the level of the thoracic aorta

    2 years

Secondary Outcomes (6)

  • 24-hour Systolic Blood Pressure

    2 years

  • 24-hour Diastolic Blood Pressure

    2 years

  • Cardiac Damage (Left Ventricular Hypertrophy at Echocardiogram or ECG)

    2 years

  • Vascular Damage (Carotid Plaque at Ultrasonography)

    2 years

  • Renal Damage (Urine Protein)

    2 years

  • +1 more secondary outcomes

Study Arms (1)

Hypertensive patients

No intervention. Patients will be sumbitted to standard tests required for hypertension management, including ambulatory blood pressure monitoring, and pharmacologically treated according to recommendations of international guidelines. The registry will include data from subjects fulfilling the inclusion criteria and whose data are contained in existing databases collected by the participating centers and who are regularly followed-up at the center. New subjects can be enrolled for this project, but they must be submitted to ambualtory blood pressure monitoring because it is required for evaluating their hypertension status, according to current recommendations.

Device: Ambulatory blood pressure monitoring

Interventions

Ambulatory blood pressure monitoring with arterial stiffness evaluation at 6-12 month intervals.

Hypertensive patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Suspected hypertensive patients referred to routine diagnostic evaluation for their condition (hypertension) or established hypertensive subjects

You may qualify if:

  • Subjects referred to routine diagnostic evaluation for hypertension or established hypertensive subject
  • ABPM performed for clinical reasons with a BPLab device
  • Valid ambualtory blood pressure recordings (interval between measurements not \>30 minutes, at least 70% of expected number of readings, at least 20 valid readings during the day-time and 7 during the night-time)
  • Availability of individual measurements for ambulatory blood pressure monitoring
  • Availability of basic demographic and clinical information
  • Availability of a signed informed consent form

You may not qualify if:

  • Age \<18 years
  • Atrial fibrillation, frequent ectopic beats, second or third degree atrioventricular blocks, or other conditions which might make difficult or unreliable the automatic blood pressure measurement with the oscillometric technique
  • Upper arm circumference \<22 cm
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (24)

DIM Clinica Privada

Buenos Aires, Argentina

Location

Servicio de Clínica Médica y Sección Hipertensión Arterial, Hospital Italiano de Buenos Aires

Buenos Aires, Argentina

Location

Center of Preventive Cardiology

Yerevan, 00014, Armenia

Location

Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University

Sydney, Australia

Location

Dipartimento di Scienze Mediche e Chirurgiche, Università di Brescia, Medicina 2, Spedali Civili

Brescia, 25100, Italy

Location

Unità Operativa di Nefrologia ed Ipertensione, Centro di Riferimento Regionale per l'Ipertensione Arteriosa, Policlinico Paolo Giaccone

Palermo, 90127, Italy

Location

Department of Functional Diagnostics, Medical Centre Hospital of President's Affairs Administration of The Republic of Kazakhstan

Astana, Kazakhstan

Location

University of Guadalajara, Dept. of Physiology

Guadalajara, 44340, Mexico

Location

Clínica da Aveleira, Instituto de Investigação e Formação Cardiovascular

Coimbra, Portugal

Location

Escola Superior de Tecnologia da Saúde de Coimbra , Instituto Politécnico de Coimbra

Coimbra, Portugal

Location

Cardiac Rehabilitation Clinic, Tirgu Mures Emergency Clinical County Hospital

Târgu Mureş, Romania

Location

South Ural State Medical University

Chelyabinsk, Russia

Location

Diagnostics Department, The Hospital within the Russian Railroad Network

Chita, Russia

Location

Department of Cardiology and Personalized Medicine, Faculty of Doctors' Advanced Training, Peoples' Friendship University of Russia

Moscow, Russia

Location

Department of Cardiology, Sechenov First Moscow State Medical University

Moscow, Russia

Location

Department of Propaedeutics of Internal Diseases, Medical Faculty, Peoples' Friendship University of Russia

Moscow, Russia

Location

Institute of Personalized Medicine, Sechenov First Moscow State Medical University

Moscow, Russia

Location

Lomonosov Moscow State University Clinic, State University

Moscow, Russia

Location

Volga District Medical Center

Nizhny Novgorod, Russia

Location

Petrosavodsk Research Center and Department of Faculty Therapy, Infectious Diseases and Epidemiology, Petrozavodsk State University

Petrozavodsk, Russia

Location

Rostov State Medical University

Rostov-at-Don, Russia

Location

North-West Federal Medical Research Centre, Department of Epidemiology

Saint Petersburg, Russia

Location

Volgograd State Medical University

Volgograd, Russia

Location

National Scientific Center "M.D. Strazhesko Institute of Cardiology"

Kyiv, Ukraine

Location

Related Publications (8)

  • Omboni S, Posokhov IN, Parati G, Avolio A, Rogoza AN, Kotovskaya YV, Mule G, Muiesan ML, Orlova IA, Grigoricheva EA, Cardona Munoz E, Zelveian PH, Pereira T, Peixoto Maldonado JM. Vascular Health Assessment of The Hypertensive Patients (VASOTENS) Registry: Study Protocol of an International, Web-Based Telemonitoring Registry for Ambulatory Blood Pressure and Arterial Stiffness. JMIR Res Protoc. 2016 Jun 29;5(2):e137. doi: 10.2196/resprot.5619.

    PMID: 27358088BACKGROUND
  • Omboni S, Posokhov IN, Kotovskaya YV, Protogerou AD, Blacher J. Twenty-Four-Hour Ambulatory Pulse Wave Analysis in Hypertension Management: Current Evidence and Perspectives. Curr Hypertens Rep. 2016 Oct;18(10):72. doi: 10.1007/s11906-016-0681-2.

    PMID: 27659178BACKGROUND
  • Omboni S, Campolo L, Panzeri E. Telehealth in chronic disease management and the role of the Internet-of-Medical-Things: the Tholomeus(R) experience. Expert Rev Med Devices. 2020 Jul;17(7):659-670. doi: 10.1080/17434440.2020.1782734. Epub 2020 Jun 30.

    PMID: 32536214BACKGROUND
  • Omboni S, Panzeri E, Campolo L. E-Health in Hypertension Management: an Insight into the Current and Future Role of Blood Pressure Telemonitoring. Curr Hypertens Rep. 2020 Jun 6;22(6):42. doi: 10.1007/s11906-020-01056-y.

    PMID: 32506273BACKGROUND
  • Omboni S, Arystan A, Benczur B. Ambulatory monitoring of central arterial pressure, wave reflections, and arterial stiffness in patients at cardiovascular risk. J Hum Hypertens. 2022 Apr;36(4):352-363. doi: 10.1038/s41371-021-00606-4. Epub 2021 Sep 13.

    PMID: 34518619BACKGROUND
  • Omboni S, Posokhov I, Parati G, Rogoza A, Kotovskaya Y, Arystan A, Avolio A, Barkan V, Bulanova N, Cardona Munoz E, Grigoricheva E, Konradi A, Minyukhina I, Muiesan ML, Mule G, Orlova I, Pereira T, Peixoto Maldonado JM, Statsenko ME, Tilea I, Waisman G; VASOTENS Registry Study Group. Ambulatory blood pressure and arterial stiffness web-based telemonitoring in patients at cardiovascular risk. First results of the VASOTENS (Vascular health ASsessment Of The hypertENSive patients) Registry. J Clin Hypertens (Greenwich). 2019 Aug;21(8):1155-1168. doi: 10.1111/jch.13623. Epub 2019 Jul 11.

  • Omboni S, Posokhov I, Parati G, Arystan A, Tan I, Barkan V, Bulanova N, Derevyanchenko M, Grigoricheva E, Minyukhina I, Mule G, Orlova I, Paini A, Peixoto Maldonado JM, Pereira T, Ramos-Becerra CG, Tilea I, Waisman G; VASOTENS Registry Study Group. Variable association of 24-h peripheral and central hemodynamics and stiffness with hypertension-mediated organ damage: the VASOTENS Registry. J Hypertens. 2020 Apr;38(4):701-715. doi: 10.1097/HJH.0000000000002312.

  • Omboni S, Alfie J, Arystan A, Avolio A, Barin E, Bokusheva J, Bulanova N, Butlin M, Cuffaro P, Derevyanchenko M, Grigoricheva E, Gurevich A, Konradi A, Muiesan ML, Paini A, Pereira T, Statsenko ME, Tan I; VASOTENS Registry Study Group. Association of 24-h central hemodynamics and stiffness with cardiovascular events and all-cause mortality. The VASOTENS Registry. J Hypertens. 2024 Sep 1;42(9):1590-1597. doi: 10.1097/HJH.0000000000003763. Epub 2024 May 15.

Related Links

MeSH Terms

Conditions

Hypertension

Interventions

Blood Pressure Monitoring, Ambulatory

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Blood Pressure DeterminationDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisMonitoring, AmbulatoryMonitoring, Physiologic

Results Point of Contact

Title
Stefano Omboni
Organization
Italian Institute of Telemedicine

Study Officials

  • Stefano Omboni, MD

    Italian Institute of Telemedicine

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 13, 2015

First Posted

October 16, 2015

Study Start

November 1, 2015

Primary Completion

December 1, 2018

Study Completion

April 1, 2022

Last Updated

December 16, 2024

Results First Posted

March 1, 2024

Record last verified: 2024-10

Locations